Medication Utilization at School Age for Children Born Preterm - 20/03/20
Doi : 10.1016/j.jpeds.2019.11.015
Jo Ann D'Agostino, DNP, CRNP 1, 2, Molly Passarella, MS 2, Ashley E. Martin, MPH 2, Scott A. Lorch, MD, MSCE 1, 2, 3, 4, ⁎ 
1 Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA
2 Center for Perinatal and Pediatric Health Disparities Research, The Children's Hospital of Philadelphia, Philadelphia, PA
3 The University of Pennsylvania School of Medicine, Philadelphia, PA
4 Senior Scholar, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
∗Reprint requests: Scott A. Lorch, MD, MSCE, The Children's Hospital of Philadelphia, Division of Neonatology, 3401 Civic Center Blvd, Philadelphia, PA 19104.The Children's Hospital of PhiladelphiaDivision of Neonatology3401 Civic Center BlvdPhiladelphiaPA19104
Abstract |
We explored medication use by children born preterm at 5-8 years of age. Compared with children born at full term, children born preterm had higher medication use that included most therapeutic classifications. Although asthma and chronic lung disease influenced use, prematurity remained an independent risk factor.
Le texte complet de cet article est disponible en PDF.Abbreviations : CLD, IRR
Plan
| Supported by an National Institutes of Health grant (R01 HD057168). The authors declare no conflicts of interest. |
© 2019
Elsevier Inc. Tous droits réservés.
Vol 219
P. 250 - avril 2020 Retour au numéro
Article précédent
- Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials
- Jonathan M. Davis, Gerri R. Baer, Susan McCune, Agnes Klein, Junko Sato, Laura Fabbri, Alexandra Mangili, Mary A. Short, Susan Tansey, Barry Mangum, Isamu Hokuto, Hidefumi Nakamura, Thomas Salaets, Karel Allegaert, Lynne Yao, Michael Blum, Joseph Toerner, Mark Turner, Ron Portman, International Neonatal Consortium
- Illicit Drug Exposures in Young Pediatric Patients Reported to the National Poison Data System, 2006-2016
- Jessica Graham, Jan Leonard, Shireen Banerji, George Sam Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?